• 9984
• EU50
• HAL
• HK50
• JNJ
• JP225
• NFLX
• ORCL
• TSLA
• UK100

Morning Bid: They do know Stargate is sci-fi, right?

Trump's presidency saw the launch of 'Stargate' venture for $500 billion in AI, impacting global markets positively, while Europe anticipates interest rate cuts amid economic challenges.

• AXP
• JNJ
• NFLX
• PG
• US500

Trump inauguration ahead with executive orders in focus - what's moving markets

Trump's inauguration focuses on his policies, TikTok's US service restoration, cryptocurrency fluctuations, upcoming corporate earnings reports, and declining oil prices.

• AXP
• CL
• EUR/USD
• JNJ
• NFLX
• NG
• PG
• US500

Take Five: We've been expecting you, Mr Trump

Investors prepare for Trump's second term, focusing on executive orders, corporate earnings, international conflicts, energy prices, and potential Bank of Japan rate hikes affecting global markets.

• AXP
• CL
• EUR/USD
• JNJ
• NFLX
• NG
• PG
• US500

Take Five: We've been expecting you, Mr Trump

Global investors brace for the impact of Trump's second presidency on markets, with executive orders, earnings reports, international relations, energy prices, and central bank policies in focus.

• BIIB
• JNJ
• LLY
• NBI
• NVO
• PFE
• US500

Biopharma industry eyes 2025 bounceback, grapples with uncertainty over Trump return

The biopharmaceutical industry seeks to rebound in 2025, navigating uncertainty from regulatory changes and potential impacts from President Trump's administration on drug pricing and vaccine policies.

• JNJ

FDA proposes standardized testing for asbestos in talc cosmetics, Reuters reports

The FDA proposes mandatory asbestos testing for talc-based cosmetics to protect consumers from cancer risks associated with asbestos contamination.

• JNJ

US FDA proposes standardized testing to detect asbestos in talc products

The FDA proposes standardized asbestos testing for talc-containing cosmetics to protect consumers and address significant health risks associated with asbestos exposure.

• CI
• JNJ

J&J accuses divisions of Cigna of helping drain its drug copay funds, WSJ reports

Johnson & Johnson is suing Cigna, alleging that the insurer drained funds meant for patients on its costly medications by collaborating with a drug-benefit middleman.

• EXEL
• GILD
• JNJ
• MRK
• NOVN
• PFE

Unsupported price hikes added $815 million to US drug spending in 2023

A report reveals five drugs accounted for $815 million in U.S. spending increases in 2023 without clinical evidence, highlighting ongoing pricing issues in the pharmaceutical industry.

• AMZN
• AVGO
• CL
• CLRB
• CVS
• DX
• EQT
• GC
• IXIC
• JNJ
• LCO
• MCD
• NKE
• NVDA
• TSLA
• UBER
• UNH
• USD/JPY
• VIX

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.22%